Medidata Solutions to Discuss Global Electronic Trials at DIA European Clinical Data Management Conference; Chief Medical Officer Ed Ikeguchi to Highlight Challenges and Opportunities of Deploying eClinical Solutions Across Multinational Studies.
Ikeguchi's presentation, "Global Trials - Challenge or Opportunity?," is scheduled for Wednesday, November 9th at 2:30 p.m., and will highlight several case studies that demonstrate global deployment of EDC software across several multinational studies. Attendees will learn about the challenges and opportunities involved when attempting to apply EDC on a global basis, including cultural differences, regulatory nuances and hosting.
This year's "Four Worlds - One Vision" conference was designed to explore the interface and integration of clinical data management, eClinical information technology and validation. In addition to Ikeguchi's presentation, Medidata Solutions will be demonstrating its Rave 5.4 electronic clinical data management solution at stand #32.
As one of Medidata's founders and the company's Chief Medical Officer, Ikeguchi focuses on regulatory compliance and 21 CFR Part 11 and is responsible for ensuring defined project goals, objectives, development strategy, resource requirements and scheduling. Ikeguchi has secured patents on Medidata's clinical trial technology and also invented several patented medical devices that have been through the clinical development process.
Prior to forming Medidata Solutions in 2000, Ikeguchi served as assistant professor of clinical urology at Columbia University and held hospital appointments at Columbia Presbyterian, Helen Hayes Hospital and White Plains Hospitals Center. Ikeguchi has served as a clinical investigator in numerous trials sponsored by both the industry and NIH, with experience in technology-based processes related to the pharmaceutical and biotechnology industries. Ikeguchi received his B.S. in Chemistry from Fordham University and his M.D. from Columbia University's College of Physicians & Surgeons.
About the Drug Information Association
With more than 22,000 members worldwide, the Drug Information Association (DIA) is the premier member driven organization encompassing the full continuum of disciplines in the pharmaceutical and related industries. The mission of the DIA is to serve and develop members by providing a neutral, global forum that promotes the exchange of information critical to professional performance and achievement. For further information, please visit www.diahome.org.
About Medidata Solutions Worldwide
Medidata Solutions helps the world's leading pharmaceutical, biotechnology and medical device companies realize the maximum potential value from their clinical research investments. Working with companies large and small, Medidata Solutions helps accelerate the process of bringing life-enhancing treatments to market - on five continents and in more than 70 countries. Innovative process design, technology and services can streamline clinical trials by providing early visibility to clinical data for faster decision-making, optimized resources and lower execution risk. Medidata Solutions' broad client base and deep clinical experience provide value for the world's leading pharmaceutical, biotechnology and medical device companies, expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. To learn more about Medidata Solutions, please visit www.mdsol.com.
|Printer friendly Cite/link Email Feedback|
|Date:||Nov 2, 2005|
|Previous Article:||Inter Parfums, Inc. Schedules Third Quarter Release and Conference Call.|
|Next Article:||Gene Logic to Present at the 2005 Rodman and Renshaw Techvest 7th Annual Healthcare Conference.|